Jesus M. Banales

Publications : 82
Aldex : 60
H-index : 22
Citations : 2535


Cancers, Vol. 14, Pages 3483: Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence

Leonardo G. Da Fonseca et 12 al.

Jul 18, 2022 in Cancers
Cancers, Vol. 14, Pages 3483: Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence Cancers doi: 10.3390/cancers14143483 Authors: Leonardo G. Da Fonseca Pedro H. Hashizume Irai Santana de Oliveira Laura Izquierdo Sanchez Lisa Rodrigues da Cunha Saud Mariana Pinheiro Xerfan Venancio Avancini Ferreira Alves Evandro Sobroza de Mello P...


Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

Paula Olaizola et 10 al.

May 13, 2022 in Nature Reviews Gastroenterology & Hepatology


Cancers, Vol. 14, Pages 2389: Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry

Lynn E. Nooijen et 19 al.

May 12, 2022 in Cancers
Background : Lymph node metastasis and positive resection margins have been reported to be major determinants of overall survival (OS) and poor recurrence free survival (RFS) for patients who underwent resection for perihilar cholangiocarcinoma (pCCA). However, the prognostic value of positive lymph nodes independently from resection margin status on OS has not been evaluated. Method : From the E...


Cells, Vol. 11, Pages 1038: DHEA Protects Human Cholangiocytes and Hepatocytes against Apoptosis and Oxidative Stress

Ewa Kilanczyk et 5 al.

Mar 18, 2022 in Cells
Primary biliary cholangitis (PBC) is a rare chronic cholestatic and immune mediated liver disease of unknown aetiology that targets intrahepatic bile duct cells (cholangiocytes) and primarily affects postmenopausal women, when their estrogen levels sharply decrease. An impaired cholangiocyte response to estrogen characterizes the terminal stage of the disease, as this is when an inefficiency of ch...


Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis—are we there yet?

Pedro M. Rodrigues, Jesus M. Banales

Dec 30, 2021 in Alimentary Pharmacology & Therapeutics


Integrative Proposal for the Use of Biomarkers in Clinical Practice Management of NAFLD/NASH

Carlos Benítez, Marco Arrese et 4 al.

Jan 1, 2020
Identification of non-alcoholic fatty liver disease (NAFLD) and discrimination of the different subgroups of patients, grouped under this umbrella term are key issues in the field of liver diseases. While liver biopsy may still be used to diagnose and stage the disease, noninvasive tools (NITs) to appropriately asses the presence of NAFLD and its severity (id est presence of NASH) or degree of pro...


Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34

Ewa Ostrycharz et 6 al.

Jan 1, 2020 in International Journal of Molecular Sciences
Biosynthesis of melatonin by cholangiocytes is essential for maintaining the function of biliary epithelium. However, this cytoprotective mechanism appears to be impaired in primary biliary cholangitis (PBC). MiR-132 has emerged as a mediator of inflammation in chronic liver diseases. The effect of melatonin on oxidative stress and bile acid-induced apoptosis was also examined in cholangiocyes ove...


MicroRNAs in Liver Diseases

Patricia Munoz-Garrido et 5 al.

Jan 1, 2013

Similar author:

Adelina Rogowska-Wrzesinska